NeuroPace (NPCE)
US Market

NeuroPace (NPCE) Financial Statements


NeuroPace Financial Overview

NeuroPace's market cap is currently ―. The company's EPS TTM is $-1.184; its P/E ratio is -6.72; NeuroPace is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 18.01M$ 16.43M$ 16.51M$ 14.47M$ 12.79M
Gross Profit$ 13.54M$ 12.23M$ 11.97M$ 10.37M$ 8.80M
EBIT-$ -5.07M$ -7.00M$ -9.14M$ -10.01M
EBITDA-$ -4.63M$ -6.52M$ -8.68M$ -9.15M
Net Income Common Stockholders$ -6.20M$ -7.26M$ -9.12M$ -10.38M$ -11.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 66.45M$ 61.35M$ 63.57M$ 67.61M$ 77.41M
Total Assets$ 107.65M$ 99.30M$ 102.23M$ 106.27M$ 114.06M
Total Debt$ 72.39M$ 71.69M$ 71.02M$ 70.37M$ 69.77M
Net Debt$ 5.94M$ 10.35M$ 7.45M$ 2.76M$ -7.64M
Total Liabilities$ 87.00M$ 82.94M$ 81.01M$ 78.78M$ 114.06M
Stockholders Equity$ 20.65M$ 16.36M$ 21.18M$ 27.49M$ 34.73M
Cash Flow-
Free Cash Flow-$ -2.31M$ -4.35M$ 122.00K-
Operating Cash Flow$ -3.30M$ -2.30M$ -4.35M$ 122.00K-
Investing Cash Flow$ 3.47M$ 4.19M$ 5.30M$ 10.07M-
Financing Cash Flow$ 8.21M$ -27.00K$ 195.00K$ -255.00K-
Currency in USD

NeuroPace Earnings and Revenue History

NeuroPace Debt to Assets

NeuroPace Cash Flow

NeuroPace Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis